ArticleJournal of clinical medicine2023

Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.

Simona Parisse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.